Open AccessChimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
Author(s) -
Delgado Julio,
CaballeroBaños Miguel,
OrtizMaldonado Valentín,
Castellà Maria,
Magnano Laura,
Juan Manel,
UrbanoIspizua Álvaro
Publication year - 2019
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/hs9.0000000000000174
Subject(s) - ibrutinib , medicine , chronic lymphocytic leukemia , idelalisib , fludarabine , bruton's tyrosine kinase , oncology , venetoclax , obinutuzumab , rituximab , chimeric antigen receptor , leukemia , cyclophosphamide , cancer research , immunology , lymphoma , tyrosine kinase , cancer , immunotherapy , chemotherapy , receptor